- Report
- March 2024
- 143 Pages
Global
From €3749EUR$3,899USD£3,216GBP
- Report
- June 2021
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- December 2018
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- March 2022
Global
From €4663EUR$4,850USD£4,001GBP
- Report
- March 2022
Global
From €4663EUR$4,850USD£4,001GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£784GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£784GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£784GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£784GBP
The T4 Test market is a segment of the In Vitro Diagnostics (IVD) industry that focuses on the detection of the hormone thyroxine (T4). T4 tests are used to diagnose and monitor thyroid disorders, such as hypothyroidism and hyperthyroidism. The tests measure the amount of T4 in the blood, which can indicate the presence of a thyroid disorder. The T4 Test market is composed of a variety of products, including reagents, instruments, and software. Reagents are used to detect the presence of T4 in the blood, while instruments are used to measure the amount of T4 in the sample. Software is used to analyze the results of the tests.
Some companies in the T4 Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more